Seragen Inc Sample Contracts

Standard Contracts

AutoNDA by SimpleDocs
between
License Agreement • June 10th, 1997 • Seragen Inc • Biological products, (no disgnostic substances) • Tokyo
WAIVER AGREEMENT
Waiver Agreement • March 31st, 1998 • Seragen Inc • Biological products, (no disgnostic substances)

This Waiver Agreement is made as of October 28, 1997, by and between Boston University, Leon C. Hirsch, Turi Josefsen, Gerald S.J. Cassidy and Loretta P. Cassidy (individually, a "Stockholder" and collectively, the "Stockholders"), Reed R. Prior ("Prior"), and Seragen, Inc. (the "Company").

AMENDMENT 4 CONSULTING AGREEMENT
Consulting Agreement • August 15th, 1997 • Seragen Inc • Biological products, (no disgnostic substances)
SERAGEN, INC.
Asset Purchase Agreement • November 7th, 1997 • Seragen Inc • Biological products, (no disgnostic substances)
WAIVER NO. 2
Employment Agreement • April 2nd, 1997 • Seragen Inc • Biological products, (no disgnostic substances)

Reference is made to the Employment Agreement dated as of November 6, 1996 between Seragen, Inc. (the "Company") and the undersigned, as amended by an Amendment No. 1 to Employment Agreement dated as of December 18, 1996 between the Company and the undersigned and as amended by Waiver to Employment Agreement dated as of January 6, 1997 between the Company and the undersigned (together the "Agreement"). Pursuant to Section 3.6 (viii) of the Agreement, the Company agreed to grant Dr. Nichols certain additional options upon the occurrence of certain events.

AutoNDA by SimpleDocs
WITNESSETH:
License Agreement • June 10th, 1997 • Seragen Inc • Biological products, (no disgnostic substances)
WAIVER
Employment Agreement • April 2nd, 1997 • Seragen Inc • Biological products, (no disgnostic substances)

Reference is made to the Employment Agreement dated as of November 6, 1996 between Seragen, Inc. (the "Company") and the undersigned, as amended by an Amendment No. 1 to Employment Agreement dated as of December 18, 1996 between the Company and the undersigned (together the "Agreement"). Pursuant to the Agreement, the Company agreed to file a registration statement on Form S-8 (the "Registration Statement") registering under the Securities Act of 1993 all shares issued or to be issued pursuant to the exercise of the stock options granted to Prior pursuant to the Agreement on or before January 6, 1997.

WAIVER NO. 3 Reference is made to the Employment Agreement dated as of January 15, 1997 between Seragen, Inc. (the "Company") and the undersigned, as amended (collectively the "Agreement"). Pursuant to the Agreement and subsequent waivers, the Company...
Employment Agreement • March 31st, 1998 • Seragen Inc • Biological products, (no disgnostic substances)

Reference is made to the Employment Agreement dated as of January 15, 1997 between Seragen, Inc. (the "Company") and the undersigned, as amended (collectively the "Agreement"). Pursuant to the Agreement and subsequent waivers, the Company agreed to file on or before December 31, 1997, a registration statement on Form S-8 (the "Registration Statement") registering under the Securities Act of 1993 all shares issued or to be issued pursuant to the exercise of the stock options granted to Ms. Chen pursuant to the Agreement.

May 11, 1998
Option and Asset Purchase Agreement • May 15th, 1998 • Seragen Inc • Biological products, (no disgnostic substances)
The Seller shall transfer the Transferred Assets to the Buyer pursuant to a bill of sale substantially in the form of Exhibit 1.01 attached hereto -2-
Asset Purchase Agreement • March 5th, 1997 • Seragen Inc • Biological products, (no disgnostic substances) • Massachusetts
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!